Reticulocyte hemoglobin content: a new frontier in iron deficiency diagnostics for major surgical patients
Abstract Background Iron deficiency (ID) is the most common nutritional deficiency among patients undergoing major surgery. Treatment of ID is straightforward, however implementing a comprehensive anemia management strategy within clinical routines is complex. Recently, reticulocyte hemoglobin conte...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Anesthesiology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12871-025-02905-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832585405415817216 |
---|---|
author | Suma Choorapoikayil Mischa J. Kotlyar Lisa Kawohl Paul P. Pratz Denana Mehic Peter Kranke Florian Rumpf Lea V. Blum Jan A. Kloka Kai Zacharowski Vanessa Neef Patrick Meybohm |
author_facet | Suma Choorapoikayil Mischa J. Kotlyar Lisa Kawohl Paul P. Pratz Denana Mehic Peter Kranke Florian Rumpf Lea V. Blum Jan A. Kloka Kai Zacharowski Vanessa Neef Patrick Meybohm |
author_sort | Suma Choorapoikayil |
collection | DOAJ |
description | Abstract Background Iron deficiency (ID) is the most common nutritional deficiency among patients undergoing major surgery. Treatment of ID is straightforward, however implementing a comprehensive anemia management strategy within clinical routines is complex. Recently, reticulocyte hemoglobin content (Ret-He) has been evaluated as an early marker for ID diagnosis. Method In this retrospective study, 2,966 major surgical patients from two University Hospitals were screened for the presence of ID and the significance of Ret-He in diagnosis ID was evaluated in both non-anemic and anemic patients. According to hemoglobin, ferritin, and transferrin saturation concentrations patients were assigned to a Control group (no anemia, no ID), ID group (no anemia, ID), IDA group (anemia, ID) or Others group (anemia, no ID). Results In total, 2,760 patients were included in analysis: Control (n = 1500; 54.2%), IDA (n = 412; 14.9%), ID (n = 487; 17.6%), and Others (n = 370; 13.4%). Ret-He was significantly decreased in the IDA group compared to ID, Control and Others, respectively (p < 0.001). The ROC curve analysis revealed an AUC of 0.842 (95% CI (0.82–0.87)) at Ret-He cutoff 33.5 pg, by which IDA was discriminated with 69.7% (95% CI (65.3–74.0%)) sensitivity and 85.7% (95% CI (82.3-86.1%)) specificity. Of the 370 patients with anemia of unknown cause (Others group) 131 had Ret-He levels < 33.5 pg. In these patients, the median values for ferritin was 492.0 ng/ml (333.5; 818.5 ng/ml) and transferrin saturation 11.9% (18.0; 23.3%). Logistic regression identified significant predictors of ID, with each decrease in Hb and Ret-He associated with a 19.4% (OR = 0.806; p < 0.001) and 26% (OR = 0.740; p < 0.001) increase in the odds of ID, respectively. Conclusion This study highlights the potential of Ret-He as a promising alternative marker for diagnosing ID in patients undergoing major surgery, particularly in cases of elevated ferritin levels or non-anemic patients. Ret-He may serve as a valuable tool to prioritize patients for further iron status testing, especially when preoperative time is limited. |
format | Article |
id | doaj-art-198c71c90915461ea7e6053172edd6e5 |
institution | Kabale University |
issn | 1471-2253 |
language | English |
publishDate | 2025-01-01 |
publisher | BMC |
record_format | Article |
series | BMC Anesthesiology |
spelling | doaj-art-198c71c90915461ea7e6053172edd6e52025-01-26T12:49:52ZengBMCBMC Anesthesiology1471-22532025-01-012511910.1186/s12871-025-02905-6Reticulocyte hemoglobin content: a new frontier in iron deficiency diagnostics for major surgical patientsSuma Choorapoikayil0Mischa J. Kotlyar1Lisa Kawohl2Paul P. Pratz3Denana Mehic4Peter Kranke5Florian Rumpf6Lea V. Blum7Jan A. Kloka8Kai Zacharowski9Vanessa Neef10Patrick Meybohm11Goethe University Frankfurt, University Hospital Frankfurt, Department of Anaesthesiology, Intensive Care and Pain TherapyUniversity Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain MedicineUniversity Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain MedicineGoethe University Frankfurt, University Hospital Frankfurt, Department of Anaesthesiology, Intensive Care and Pain TherapyGoethe University Frankfurt, University Hospital Frankfurt, Department of Anaesthesiology, Intensive Care and Pain TherapyUniversity Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain MedicineUniversity Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain MedicineGoethe University Frankfurt, University Hospital Frankfurt, Department of Anaesthesiology, Intensive Care and Pain TherapyGoethe University Frankfurt, University Hospital Frankfurt, Department of Anaesthesiology, Intensive Care and Pain TherapyGoethe University Frankfurt, University Hospital Frankfurt, Department of Anaesthesiology, Intensive Care and Pain TherapyGoethe University Frankfurt, University Hospital Frankfurt, Department of Anaesthesiology, Intensive Care and Pain TherapyUniversity Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain MedicineAbstract Background Iron deficiency (ID) is the most common nutritional deficiency among patients undergoing major surgery. Treatment of ID is straightforward, however implementing a comprehensive anemia management strategy within clinical routines is complex. Recently, reticulocyte hemoglobin content (Ret-He) has been evaluated as an early marker for ID diagnosis. Method In this retrospective study, 2,966 major surgical patients from two University Hospitals were screened for the presence of ID and the significance of Ret-He in diagnosis ID was evaluated in both non-anemic and anemic patients. According to hemoglobin, ferritin, and transferrin saturation concentrations patients were assigned to a Control group (no anemia, no ID), ID group (no anemia, ID), IDA group (anemia, ID) or Others group (anemia, no ID). Results In total, 2,760 patients were included in analysis: Control (n = 1500; 54.2%), IDA (n = 412; 14.9%), ID (n = 487; 17.6%), and Others (n = 370; 13.4%). Ret-He was significantly decreased in the IDA group compared to ID, Control and Others, respectively (p < 0.001). The ROC curve analysis revealed an AUC of 0.842 (95% CI (0.82–0.87)) at Ret-He cutoff 33.5 pg, by which IDA was discriminated with 69.7% (95% CI (65.3–74.0%)) sensitivity and 85.7% (95% CI (82.3-86.1%)) specificity. Of the 370 patients with anemia of unknown cause (Others group) 131 had Ret-He levels < 33.5 pg. In these patients, the median values for ferritin was 492.0 ng/ml (333.5; 818.5 ng/ml) and transferrin saturation 11.9% (18.0; 23.3%). Logistic regression identified significant predictors of ID, with each decrease in Hb and Ret-He associated with a 19.4% (OR = 0.806; p < 0.001) and 26% (OR = 0.740; p < 0.001) increase in the odds of ID, respectively. Conclusion This study highlights the potential of Ret-He as a promising alternative marker for diagnosing ID in patients undergoing major surgery, particularly in cases of elevated ferritin levels or non-anemic patients. Ret-He may serve as a valuable tool to prioritize patients for further iron status testing, especially when preoperative time is limited.https://doi.org/10.1186/s12871-025-02905-6Hemoglobin equivalentRet-HeSurgeryRet-HbAnemia screening |
spellingShingle | Suma Choorapoikayil Mischa J. Kotlyar Lisa Kawohl Paul P. Pratz Denana Mehic Peter Kranke Florian Rumpf Lea V. Blum Jan A. Kloka Kai Zacharowski Vanessa Neef Patrick Meybohm Reticulocyte hemoglobin content: a new frontier in iron deficiency diagnostics for major surgical patients BMC Anesthesiology Hemoglobin equivalent Ret-He Surgery Ret-Hb Anemia screening |
title | Reticulocyte hemoglobin content: a new frontier in iron deficiency diagnostics for major surgical patients |
title_full | Reticulocyte hemoglobin content: a new frontier in iron deficiency diagnostics for major surgical patients |
title_fullStr | Reticulocyte hemoglobin content: a new frontier in iron deficiency diagnostics for major surgical patients |
title_full_unstemmed | Reticulocyte hemoglobin content: a new frontier in iron deficiency diagnostics for major surgical patients |
title_short | Reticulocyte hemoglobin content: a new frontier in iron deficiency diagnostics for major surgical patients |
title_sort | reticulocyte hemoglobin content a new frontier in iron deficiency diagnostics for major surgical patients |
topic | Hemoglobin equivalent Ret-He Surgery Ret-Hb Anemia screening |
url | https://doi.org/10.1186/s12871-025-02905-6 |
work_keys_str_mv | AT sumachoorapoikayil reticulocytehemoglobincontentanewfrontierinirondeficiencydiagnosticsformajorsurgicalpatients AT mischajkotlyar reticulocytehemoglobincontentanewfrontierinirondeficiencydiagnosticsformajorsurgicalpatients AT lisakawohl reticulocytehemoglobincontentanewfrontierinirondeficiencydiagnosticsformajorsurgicalpatients AT paulppratz reticulocytehemoglobincontentanewfrontierinirondeficiencydiagnosticsformajorsurgicalpatients AT denanamehic reticulocytehemoglobincontentanewfrontierinirondeficiencydiagnosticsformajorsurgicalpatients AT peterkranke reticulocytehemoglobincontentanewfrontierinirondeficiencydiagnosticsformajorsurgicalpatients AT florianrumpf reticulocytehemoglobincontentanewfrontierinirondeficiencydiagnosticsformajorsurgicalpatients AT leavblum reticulocytehemoglobincontentanewfrontierinirondeficiencydiagnosticsformajorsurgicalpatients AT janakloka reticulocytehemoglobincontentanewfrontierinirondeficiencydiagnosticsformajorsurgicalpatients AT kaizacharowski reticulocytehemoglobincontentanewfrontierinirondeficiencydiagnosticsformajorsurgicalpatients AT vanessaneef reticulocytehemoglobincontentanewfrontierinirondeficiencydiagnosticsformajorsurgicalpatients AT patrickmeybohm reticulocytehemoglobincontentanewfrontierinirondeficiencydiagnosticsformajorsurgicalpatients |